Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
HIV Clinical Trials|May 17, 2015
Differences in antiretroviral safety and efficacy by sex in a multinational randomized clinical trialCynthia Firnhaber, Laura M Smeaton, Beatriz Grinsztejn, et al.
Antiviral Therapy|October 26, 2011
Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in AfricaWolfgang Stöhr, Andrew Reid, A Sarah Walker, et al.
Plos One|February 26, 2013
A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteriaCharles F Gilks, A Sarah Walker, Paula Munderi, et al.
Value in Health Regional Issues|November 25, 2016
Measuring and Valuing Informal Care for Economic Evaluation of HIV/AIDS Interventions: Methods and Application in MalawiLevison S Chiwaula, Paul Revill, Deborah Ford, et al.
AIDS (London, England)|February 1, 2023
Impact of sub-optimal HIV viral control on activated T cellsFrancesca I F Arrigoni, Moira Spyer, Patricia Hunter, et al.
AIDS (London, England)|March 23, 2017
Hepatitis B serological markers and plasma DNA concentrationsHuw Price, David Dunn, Tamale Zachary, et al.
Plos One|October 19, 2020
Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV "Treat All" in ZimbabweRichard Makurumidze, Jozefien Buyze, Tom Decroo, et al.
The Journal of Infectious Diseases|May 7, 2014
25-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settingsFiona Havers, Laura Smeaton, Nikhil Gupte, et al.
Plos One|January 8, 2020
Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015Richard Makurumidze, Tsitsi Mutasa-Apollo, Tom Decroo, et al.
American Journal of Epidemiology|August 29, 2015
The Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal Structural ModelsDeborah Ford, James M Robins, Maya L Petersen, et al.
Pageof 9